| __timestamp | Iovance Biotherapeutics, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 9335772 | 9216000000 |
| Thursday, January 1, 2015 | 999000 | 8296000000 |
| Friday, January 1, 2016 | 978000 | 10044000000 |
| Sunday, January 1, 2017 | 952000 | 11560000000 |
| Monday, January 1, 2018 | 956000 | 10558000000 |
| Tuesday, January 1, 2019 | 8122999 | 9351000000 |
| Wednesday, January 1, 2020 | 8712000 | 8933000000 |
| Friday, January 1, 2021 | 13980000 | 8284000000 |
| Saturday, January 1, 2022 | 21135000 | 7952000000 |
| Sunday, January 1, 2023 | 10755000 | 8200000000 |
| Monday, January 1, 2024 | 8480000000 |
Data in motion
In the ever-evolving pharmaceutical landscape, Teva Pharmaceutical Industries Limited and Iovance Biotherapeutics, Inc. present a fascinating study in contrasts. Over the past decade, Teva's cost of revenue has consistently dwarfed that of Iovance, with figures reaching up to 1.16 billion in 2017. In stark contrast, Iovance's cost of revenue peaked at a modest 21 million in 2022. This disparity highlights the scale and operational differences between a global pharmaceutical giant and a burgeoning biotech firm.
From 2014 to 2023, Teva's cost of revenue saw a gradual decline of approximately 14%, reflecting strategic shifts and market challenges. Meanwhile, Iovance experienced a dramatic increase of over 1000%, indicative of its growth trajectory and expanding operations. This comparison underscores the dynamic nature of the pharmaceutical industry, where established players and newcomers navigate distinct paths to success.
Cost of Revenue Comparison: Eli Lilly and Company vs Teva Pharmaceutical Industries Limited
Cost of Revenue Comparison: Johnson & Johnson vs Teva Pharmaceutical Industries Limited
Cost of Revenue Comparison: Merck & Co., Inc. vs Iovance Biotherapeutics, Inc.
Cost of Revenue Comparison: AstraZeneca PLC vs Iovance Biotherapeutics, Inc.
Cost of Revenue: Key Insights for Pfizer Inc. and Teva Pharmaceutical Industries Limited
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and PTC Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Teva Pharmaceutical Industries Limited vs Wave Life Sciences Ltd.
Comparing Cost of Revenue Efficiency: BioMarin Pharmaceutical Inc. vs Iovance Biotherapeutics, Inc.
Alkermes plc vs Iovance Biotherapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for ADMA Biologics, Inc. and Iovance Biotherapeutics, Inc.
Comparing Cost of Revenue Efficiency: Iovance Biotherapeutics, Inc. vs Taro Pharmaceutical Industries Ltd.
Cost of Revenue: Key Insights for Iovance Biotherapeutics, Inc. and MiMedx Group, Inc.